Bromide

Bromide

SCHEMBL6921806

Br.Oc1ccccc1C1CCNCC1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A2 known ✓ P23975 5/20 0.50
SLC6A4 known ✓ P31645 5/20 0.50
SLC6A3 known ✓ Q01959 5/20 0.50
HTR1A known ✓ P08908 4/20 0.50
SIGMAR1 known ✓ Q99720 1/20 0.50
ADRB2 known ✓ P07550 1/20 0.47
HTR2C P28335 10/20 0.58
SLC18A3 Q16572 1/20 0.50
QDPR P09417 1/20 0.47
GABRA1 P14867 3/20 0.46
GABRB2 P47870 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614050 0.98 HTR2C (0.60) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL4530764 0.86 CHRNB2 (0.47) HTR2CSLC18A3SIGMAR1
SCHEMBL3992205 0.83 MEN1 (0.50) HTR2C
SCHEMBL30493303 0.83 HTR2C (0.72) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL929830 0.83 MEN1 (0.50) HTR2C
SCHEMBL24947638 0.82 HTR2C (0.53) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
Hydrochloric Acid SCHEMBL28731235 0.81 HTR2C (0.54) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
Tert-Butyl Formate SCHEMBL27704472 0.80 HTR2C (0.50) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL24310432 0.79 HTR2C (0.50) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL27952492 0.79 HTR2C (0.69) HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030120070-A1 Serotonin 5-HT1A and dopamin D2 receptor ligands H. LUNDBECK A/S (DE) 2003-06-26 US disclosed
US-6514993-B1 Useful in the treatment of certain psychic and neurologic disorders H. LUNDBECK A/S (DK) 2003-02-04 US disclosed
EP-0770066-B1 SEROTONIN 5-HT 1A AND DOPAMIN D2 RECEPTOR LIGANDS LUNDBECK & CO AS H (DK) 2000-05-17 EP disclosed
EP-0770066-A1 SEROTONIN 5-HT 1A AND DOPAMIN D2 RECEPTOR LIGANDS H. LUNDBECK A/S (DK) 1997-05-02 EP disclosed
WO-1995033729-A1 SEROTONIN 5-HT1A AND DOPAMIN D2 RECEPTOR LIGANDS H. LUNDBECK A/S (DK) 1995-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030120070-A1 Serotonin 5-HT1A and dopamin D2 receptor ligands HTR5A, HTR2C, HTR1D SLC6A2 136/4885SLC6A4 138/4885SLC6A3 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.